- Home
- CTSO vs PVL Comparison
CTSO vs PVL Comparison
Compare CTSO & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- PVL
- Stock Information
- Founded
- CTSO 1997
- PVL 2011
- Country
- CTSO United States
- PVL United States
- Employees
- CTSO N/A
- PVL N/A
- Industry
- CTSO Medical/Dental Instruments
- PVL Oil & Gas Production
- Sector
- CTSO Health Care
- PVL Energy
- Exchange
- CTSO Nasdaq
- PVL Nasdaq
- Market Cap
- CTSO 72.8M
- PVL 60.1M
- IPO Year
- CTSO N/A
- PVL N/A
- Fundamental
- Price
- CTSO $0.89
- PVL $1.98
- Analyst Decision
- CTSO Buy
- PVL
- Analyst Count
- CTSO 2
- PVL 0
- Target Price
- CTSO $5.50
- PVL N/A
- AVG Volume (30 Days)
- CTSO 351.0K
- PVL 59.3K
- Earning Date
- CTSO 08-07-2025
- PVL 01-01-0001
- Dividend Yield
- CTSO N/A
- PVL 4.24%
- EPS Growth
- CTSO N/A
- PVL N/A
- EPS
- CTSO N/A
- PVL 0.09
- Revenue
- CTSO $36,107,520.00
- PVL $4,598,992.00
- Revenue This Year
- CTSO $11.15
- PVL N/A
- Revenue Next Year
- CTSO $21.39
- PVL N/A
- P/E Ratio
- CTSO N/A
- PVL $20.84
- Revenue Growth
- CTSO 20.18
- PVL 37.78
- 52 Week Low
- CTSO $0.71
- PVL $1.30
- 52 Week High
- CTSO $1.61
- PVL $2.00
- Technical
- Relative Strength Index (RSI)
- CTSO 41.50
- PVL 69.00
- Support Level
- CTSO $1.03
- PVL $1.77
- Resistance Level
- CTSO $1.19
- PVL $1.90
- Average True Range (ATR)
- CTSO 0.09
- PVL 0.06
- MACD
- CTSO 0.01
- PVL 0.01
- Stochastic Oscillator
- CTSO 27.21
- PVL 100.00
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.